Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)
India · Delayed Price · Currency is INR 969.00
-8.20 (-0.84%)
Sep 11, 2026, 3:29 PM IST
NSE:YATHARTH Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 13,406 | 12,072 | 8,856 | 6,705 | 5,203 | 4,009 |
Other Revenue | 257.87 | - | - | 26.92 | 21.96 | 9.34 |
| 13,664 | 12,072 | 8,856 | 6,732 | 5,225 | 4,019 | |
Revenue Growth | 47.48% | 36.31% | 31.55% | 28.85% | 30.01% | 75.74% |
Cost of Revenue | 5,160 | 4,692 | 3,389 | 2,503 | 1,849 | 1,618 |
Gross Profit | 8,503 | 7,380 | 5,467 | 4,229 | 3,376 | 2,401 |
Selling, General & Admin | - | 309.43 | 228.1 | 73.14 | 63.38 | 29.46 |
Other Operating Expenses | 5,067 | 4,140 | 2,985 | 2,327 | 1,951 | 1,253 |
Operating Expenses | 6,078 | 5,327 | 3,785 | 2,693 | 2,290 | 1,561 |
Operating Income | 2,425 | 2,053 | 1,682 | 1,536 | 1,086 | 839.53 |
Interest Expense | -129.37 | -65.35 | -75.11 | -94.18 | -213.87 | -214.86 |
Interest & Investment Income | - | 195.32 | 78.48 | 126.91 | 4.28 | 6.4 |
Currency Exchange Gain (Loss) | - | -4.91 | - | - | - | - |
Other Non Operating Income (Expenses) | -34.82 | 34.77 | 3.03 | 0.02 | - | -0.02 |
EBT Excluding Unusual Items | 2,261 | 2,213 | 1,688 | 1,568 | 876.78 | 631.05 |
Gain (Loss) on Sale of Investments | - | 27.78 | 28.9 | - | - | - |
Gain (Loss) on Sale of Assets | - | -4.51 | - | - | - | - |
Asset Writedown | - | -0.41 | - | - | - | - |
Pretax Income | 2,261 | 2,236 | 1,717 | 1,568 | 876.78 | 631.05 |
Income Tax Expense | 523.89 | 532.55 | 411.89 | 423.58 | 219.1 | 189.43 |
Earnings From Continuing Operations | 1,737 | 1,703 | 1,306 | 1,145 | 657.68 | 441.62 |
Minority Interest in Earnings | 67.17 | 50.75 | -0.05 | - | - | - |
Net Income | 1,804 | 1,754 | 1,305 | 1,145 | 657.68 | 441.62 |
Net Income to Common | 1,804 | 1,754 | 1,305 | 1,145 | 657.68 | 441.62 |
Net Income Growth | 26.87% | 34.34% | 14.04% | 74.06% | 48.92% | 143.18% |
Shares Outstanding (Basic) | 96 | 96 | 89 | 79 | 66 | 66 |
Shares Outstanding (Diluted) | 96 | 96 | 89 | 79 | 66 | 66 |
Shares Change | 5.45% | 8.67% | 11.86% | 20.99% | - | - |
EPS (Basic) | 18.73 | 18.20 | 14.72 | 14.44 | 10.04 | 6.74 |
EPS (Diluted) | 18.73 | 18.20 | 14.72 | 14.44 | 10.04 | 6.74 |
EPS Growth | 20.31% | 23.64% | 1.93% | 43.86% | 48.92% | 143.34% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1,120 | -1,708 | -964.43 | 439.7 | 468.01 |
Free Cash Flow Per Share | - | -11.63 | -19.26 | -12.17 | 6.71 | 7.14 |
Gross Margin | 62.23% | 61.14% | 61.73% | 62.82% | 64.62% | 59.74% |
Operating Margin | 17.75% | 17.01% | 18.99% | 22.81% | 20.79% | 20.89% |
Profit Margin | 13.20% | 14.53% | 14.74% | 17.00% | 12.59% | 10.99% |
Free Cash Flow Margin | - | -9.28% | -19.28% | -14.32% | 8.42% | 11.65% |
EBITDA | 3,386 | 2,889 | 2,228 | 1,808 | 1,340 | 1,097 |
EBITDA Margin | 24.78% | 23.93% | 25.16% | 26.85% | 25.65% | 27.31% |
D&A For EBITDA | 961.11 | 836.08 | 545.88 | 271.94 | 254 | 257.92 |
EBIT | 2,425 | 2,053 | 1,682 | 1,536 | 1,086 | 839.53 |
EBIT Margin | 17.75% | 17.01% | 18.99% | 22.81% | 20.79% | 20.89% |
Effective Tax Rate | 23.17% | 23.82% | 23.98% | 27.01% | 24.99% | 30.02% |
Revenue as Reported | 13,629 | 12,330 | 8,967 | 6,862 | 5,231 | 4,026 |